| Bioactivity | Granotapide (JTT-130) is an orally active microsomal triglyceride transfer protein (MTP) inhibitor. Granotapide reduces absorption of cholesterol and triglycerides through inhibition of MTP. Granotapide can be used for the research of dyslipidemia[1]. |
| CAS | 594842-13-4 |
| Formula | C39H37F3N2O8 |
| Molar Mass | 718.71 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhao HP, et al. Discontinued drugs in 2012: cardiovascular drugs. Expert Opin Investig Drugs. 2013 Nov;22(11):1437-51. |
Granotapide
CAS: 594842-13-4 F: C39H37F3N2O8 W: 718.71
Granotapide (JTT-130) is an orally active microsomal triglyceride transfer protein (MTP) inhibitor. Granotapide reduces
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.